CPDR Biospecimen Banks
New Challenges in Predicting the Clinical Course for CaP Patients
It is worth noting that well-characterized biospecimens from our group and others have already contributed immensely to the novel molecular discoveries made in the field of CaP research. Therefore, with a proven track record, the continued development and enhancement of the CPDR Biospecimen Bank holds great promise for much needed translational research at CPDR and at other institutions through collaborative research agreements.
The biospecimen storage and processing facilities that comprise the CPDR Biospecimen Bank are housed in four locations: the Walter Reed National Military Medical Center (WRNNMC) in Bethesda, MD; the headquarters of the Center for Prostate Disease Research (CPDR) in Rockville, MD; the Joint Pathology Center (JPC) in Washington, DC, and the Prostate Cell Center at the Department of Surgery of the Uniformed Services University (USU) in Bethesda, MD. These facilities have been processing biospecimens since 1993 and have a significant endowment of biospecimen resources. The biospecimen resources and analytical and processing services provided by these facilities have supported numerous studies conducted at the CPDR. These studies have resulted in over 60 peer-reviewed publications, 10 grants or CRADA, and five patents to date.
- Radical Prostatectomy Specimen Processing for Frozen Tissue Bank Generation
- Histological Characterization
- Radical Prostatectomy Specimen Processing for Fixed, Paraffin-embedded Tissue Bank Generation
- Laser Capture Microdissection (LCM) of Prostate Tissues and Generation of
LCM/RNA and Genomic DNA Bank
- Development of Tissue Microarrays (TMA)
- Peripheral Blood Collection and Processing to Generate Serum and genomic DNA Banks
- Serum Preparation
- Peripheral Blood DNA Bank
More recently, active collaborations have been sought by corporate partners and academic leaders to use CPDR Bio-specimens bank. A Biospecimen Oversight Committee and Research Opportunity Evaluation Committee have been instituted recently to monitor the prioritization of bio-specimens for in-house use and collaborations.
CPDR WEEKLY SEMINAR
Albert Dobi, PhD
Associate Director, BSRP
Research Associate Professor of Surgery, USUHS
Presentation: "Enhancing the Impact of Basic Science and Translational Research in the Context of Mission "
Date: March 24, 2017
Time: 9:00am -10:00am
Location: CPDR, Rockville, MD
2nd floor conference room
Read the March 2017 CPDR E-Newsletter
June 23, 2016
by Paula Amann
Published in the June 2016 issue of Military Medical Research News, a monthly newsletter of the Department of Research Programs, Walter Reed National Military Medical Center.
Fine-tuning facial transplants, predicting bone fractures, shrinking prostate cancers with new drugs and cutting the costs of surgical training with the right technology: These were among the problems probed by competition winners for 2016 Research and Innovation Month at Walter Reed National Military Medical Center (WRNMMC).
RAP winners included LT Daniel Griffin, MC (resident laboratory category); CPT Sarah Placek, MC (resident clinical); Charles P. Xavier, Ph.D. (staff laboratory); and Benjamin Sheffield (staff clinical).
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag
Genes Cancer. 2016 Nov;7(11-12):394-413. doi: 10.18632/genesandcancer.126.
Re: Inherited DNA-repair Gene Mutations in Men with Metastatic Prostate Cancer
Eur Urol. 2017 Jan 5. pii: S0302-2838(16)30922-8. doi: 10.1016/j.eururo.2016.12.018. [Epub ahead of print]